Publications

Please find the list of scientific publications of team members below

Publications

Sorted: reverse chronological order

Version: 2021-10-07

  1. Massive GIST as first manifestation of neurofibromatosis type I. Küchler B, Heinritz W, Bier A, Reif S, Grossmann M, Jänecke C, Plaschke J, Krüger S. European Journal of Human Genetics 2020;28:517
  2. Phenotype of males and females with C-terminal truncating mutations in MECP2. Grossmann M, Zacher P, Heinritz W, Bier A, Reif S, Plaschke J, Klaschka V, Jänecke C, Kreuz FR, Krüger S. Medizinische Genetik. 2019;31(1):124
  3. Severe phenotype of PCDH19-related X-linked epilepsy in a girl with Triple X syndrome. Küchler B, Rieger M, Reif S, Bier A, Plaschke J, Kreuz FR, Krüger S, Weidner B, Heinritz W. Medizinische Genetik. 2017;29(1):145-146
  4. A CADASIL-like phenotype in patients with cysteine-sparing mutations in the NOTCH3 gene. Klaschka V, Zacher P, Rieger M, Bier A, Reif S, Kreuz FR, Plaschke J, Schneiders R, Heinritz W, Kinzel M, Krüger S, Grossmann M. Medizinische Genetik. 2016;28(1):157
  5. Chediak-Higashi syndrome is an important differential diagnosis in oculocutaneous albinism with substantial clinical consequences. Bier A, Schneider J, Seidel J, Kentouche K, Plaschke J, Reif S, Kreuz FR, Krüger S. Medizinische Genetik. 2015;27(1):181
  6. Camurati-Engelmann disease: differential diagnosis for neuro-muscular disorders in childhood. Klaschka V, Aikele P, Haupt S, Binder S, Krüger S, Bier A, Plaschke J, Reif S, Kreuz FR. Medizinische Genetik. 2015;27(1):133
  7. A novel strumpellin mutation and potential pitfalls in the molecular diagnosis of hereditary spastic paraplegia type SPG8. Jahic A, Kreuz F, Zacher P, Fiedler J, Bier A, Reif S, Rieger M, Krüger S, Beetz C, Plaschke J. J Neurol Sci. 2014 Dec 15;347(1-2):372-4.
  8. SKI gene analysis clarifies the diagnosis in cases suspected of Shprintzen-Goldberg syndrome. Krüger S, Graul-Neumann L, Grossmann M, Bier A, Tinschert S, Robinson P N, Müller D, Albrecht B, Plaschke J, Horn D. Eur J Hum Genet. 2014 May;22(Suppl1):232
  9. A novel missense mutation in CACNA1A evaluated by in silico protein modeling is associated with non-episodic spinocerebellar ataxia with slow progression. Bürk K, Kaiser F, Tennstedt S, Schöls L, Kreuz FR, Wieland T, Strom TM, Büttner T, Hollstein R, Braunholz D, Plaschke J, Gillessen-Kaesbach G, Zühlke C. Eur J Med Genet. 2014 Apr;57(5):207-11.
  10. The first gross genomic in-frame duplication of FBN1 in humans could define a new subclass of Marfan syndrome. Zacher P, Robinson PN, Reif S, Kreuz FR, Plaschke J, Krüger S, Bier A. Medizinische Genetik. 2014;26(1):159
  11. A new missense germline mutation affecting the proofreading domain of polymerase d (POLD1) apparently predisposes to colorectal adenomas and carcinomas. Grossmann M, Kinzel M, Reif S, Kreuz FR, Plaschke J, Krüger S. Medizinische Genetik. 2014;26(1):119
  12. First case of Muir-Torre syndrome caused by a germline mutation in PMS2. Bier A, Jatzwauk M, Plaschke J, Reif S, Kreuz FR, Kinzel M, Krüger S. Eur J Hum Genet. 2013 Jun;21(Suppl2):311
  13. Second case of COFS Syndrome type 2 confirmed by compound heterozygous mutations in ERCC2. Krüger S, Bier A, Plaschke J, Reif S, Jatzwauk M, Kreuz FR, Storcks A, Spranger S. Eur J Hum Genet. 2013 Jun;21(Suppl2):219
  14. Aberrant protein expression and frequent allelic loss of MSH3 in colorectal cancer with low-level microsatellite instability. Plaschke J, Preußler M, Ziegler A, Schackert HK. Int J Colorectal Dis. 2012 Jul;27(7):911-9
  15. Hereditary Spastic Paraplegia Type 8 (SPG8): A novel mutation in a German family. Kreuz FR, Fiedler J, Bier A, Reif S, Krüger S, Plaschke J. Eur J Hum Genet. 2012 Jun;20(Suppl 1):100
  16. Unusual Phenotype of Brachydactyly in a Patient with a GDF5 Splice Mutation. Rieger M, Mundlos S, Reif S, Kreuz FR, Plaschke J, Krüger S, Bier A. Eur J Hum Genet. 2012 Jun;20(Suppl 1):60
  17. Two cases of Pontocerebellar Hypoplasia Type 2: clinical, neuroradiological and moleculargenetical findings. Bier A, Finetti C, Böhrer-Rabel H, Reif S, Plaschke J, Kreuz FR, Krüger S. Eur J Hum Genet. 2011 May;19(Suppl 2):115
  18. Pontocerebellar Hypoplasia suspected by Magnetic Resonance Imaging and confirmed by Mutation Detection. Krüger S, Finetti C, Böhrer-Rabel H, Bier A, Reif S, Plaschke J, Kreuz FR. Medizinische Genetik. 2011;23(1):111-2
  19. Differentiation of Westphal variant of Huntington’s disease and juvenile Parkinson’s disease. Kreuz F, Hille K, Guthke K, Bier A, Reif S, Plaschke J, Krüger St. Medizinische Genetik. 2011;23(1):178
  20. TCF-3, 4 protein expression correlates with ß-catenin expression in MSS and MSI-H colorectal cancer from HNPCC patients but not in sporadic colorectal cancers. Balaz P, Plaschke J, Krüger S, Görgens H, Schackert HK. Int J Colorectal Dis. 2010;25:931-9
  21. ARSACS – first analysis of SACS gene in Germany and identification of novel mutations. Kreuz FR, Timmann D, Gerwig M, Synofzik M, Schöls L, Schwarz J, Della Marina A, Sarpong A, Hoffjan S, Minnerop M, Bier A, Reif S, Plaschke J, Krüger S. Medizinische Genetik. 2010;22(1):174
  22. Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Taioli E, Garza MA, Ahn YO, Bishop DT, Bost J, Budai B, Chen K, Gemignani F, Keku T, Lima CS, Le Marchand L, Matsuo K, Moreno V, Plaschke J, Pufulete M, Thomas SB, Toffoli G, Wolf CR, Moore CG, Little J. Am J Epidemiol. 2009 Nov 15;170(10):1207-21
  23. Compound heterozygous germline sequence variants in MLH1 in a girl with early onset and sequential occurrence of two distinct lymphomas and clinical signs of Klippel-Trenaunay Syndrome. Nathrath M, Rodehüser M, Plaschke J, Krueger S. Hematology Meeting Reports. 2009;3(5):4
  24. A germline mutation in the hypocretin (HCRT) gene in a patient with narcolepsy. Kreuz FR, Wilk J, Plaschke J, Bier A, Reif S, Lohse L, Krüger S. Medizinische Genetik. 2009;21(1):139-40
  25. Microsatellite instability and loss of heterozygosity in squamous cell carcinoma of the head and neck. Koy S, Plaschke J, Luksch H, Friedrich K, Kuhlisch E, Eckelt U, Martinez R. Head Neck. 2008 Aug;30(8):1105-13
  26. No association between MUTYH and MSH6 germline mutations in 64 HNPCC patients. Steinke V, Rahner N, Morak M, Keller G, Schackert HK, Görgens H, Schmiegel W, Royer-Pokora B, Dietmaier W, Kloor M, Engel C, Propping P, Aretz S; German HNPCC Consortium*. Eur J Hum Genet. 2008 May;16(5):587-92, *Bier A, Kreuz FR, Plaschke J as member of the German HNPCC Consortium
  27. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Pistorius S, Gorgens H, Plaschke J, Hoehl R, Kruger S, Engel C, Saeger HD, Schackert HK. Cancer Lett. 2007 Apr 8;248(1):89-95
  28. N-Acetyltransferase (NAT) 2 acetylator status and age of tumour onset in patients with sporadic and familial, microsatellite stable (MSS) colorectal cancer. Pistorius S, Goergens H, Engel C, Plaschke J, Krueger S, Hoehl R, Saeger HD, Schackert HK. Int J Colorectal Dis. 2007 Feb;22(2):137-43
  29. Absence of Association between Cyclin D1 (CCND1) G870A Polymorphism and Age of Onset in Hereditary Nonpolyposis Colorectal Cancer. Kruger S, Engel C, Bier A, Mangold E, Pagenstecher C, von Knebel Doeberitz M, Holinski-Feder E, Moeslein G, Keller G, Kunstmann E, Friedl W, Plaschke J, Rüschoff J, Schackert HK and The German HNPCC-Consortium. Cancer Lett. 2006;236(2):191-7
  30. Prevalence of the mismatch-repair-deficient phenotype in colonic adenomas arising in HNPCC patients: results of a 5-year follow-up study. German HNPCC Consortium*; Muller A, Beckmann C, Westphal G, Bocker Edmonston T, Friedrichs N, Dietmaier W, Brasch FE, Kloor M, Poremba C, Keller G, Aust DE, Fass J, Buttner R, Becker H, Ruschoff J. Int J Colorectal Dis. 2006 Oct;21(7):632-41 *Kreuz FR, Kruger S, Plaschke J as member of the German HNPCC Consortium
  31. Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients. Pistorius S, Kruger S, Hohl R, Plaschke J, Distler W, Saeger HD, Schackert HK. Gynekol Oncol. 2006 Aug;102(2):189-94
  32. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor. Plaschke J, Linnebacher M, Kloor M, Gebert J, Cremer FW, Tinschert S, Aust DE, von Knebel Doeberitz M, Schackert HK. Eur J Hum Genet. 2006 May;14(5):561-6
  33. Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer. Engel C, Forberg J, Holinski-Feder E, Pagenstecher C, Plaschke J, Kloor M, Poremba C, Pox CP, Ruschoff J, Keller G, Dietmaier W, Rummele P, Friedrichs N, Mangold E, Buettner R, Schackert HK, Kienle P, Stemmler S, Moeslein G, Loeffler M; German HNPCC Consortium*. Int J Cancer. 2006 Jan 1;118(1):115-122, *Kreuz FR, Kruger S as member of the German HNPCC Consortium
  34. The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC). Kruger S, Bier A, Engel C, Mangold E, Pagenstecher C, von Knebel Doeberitz M, Holinski-Feder E, Moeslein G, Schulmann K, Plaschke J, Rüschoff J, Schackert HK and The German HNPCC-Consortium. J Med Genet. 2005 Oct;42(10):769-73
  35. Microsatellite analysis of hereditary nonpolyposis colorectal cancer-associated colorectal adenomas by laser-assisted microdissection: correlation with mismatch repair protein expression provides new insights in early steps of tumorigenesis. Giuffre G, Muller A, Brodegger T, Bocker-Edmonston T, Gebert J, Kloor M, Dietmaier W, Kullmann F, Buttner R, Tuccari G, Ruschoff J; German HNPCC Consortium*, German Cancer Aid, (Deutsche Krebshilfe). J Mol Diagn. 2005 May;7(2):160-70, *Kreuz FR, Kruger S, Plaschke J as member of the German HNPCC Consortium
  36. Microsatellite instability of selective target genes in HNPCC-associated colon adenomas. Woerner SM, Kloor M, Mueller A, Rueschoff J, Friedrichs N, Buettner R, Buzello M, Kienle P, Knaebel HP, Kunstmann E, Pagenstecher C, Schackert HK, Moslein G, Vogelsang H, von Knebel Doeberitz M, Gebert JF; German HNPCC Consortium*. Oncogene. 2005 Apr 7;24(15):2525-35, *Kruger S, Plaschke J as member of the German HNPCC Consortium
  37. HNPCC based on MSH6 mutations is characterized by later age of disease onset and lower incidence of colorectal cancer compared to MLH1 and MSH2 mutations: The german HNPCC-Consortium. Plaschke J, Engel C, Kruger S, Holinski-Feder E, Pagenstecher C, Mangold E, Moeslein G, Schulmann K, Gebert J, von Knebel Doeberitz M, Rüschoff J, Loeffler M, Schackert HK. Medizinische Genetik. 2005;17(1):82
  38. The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC). Kruger S, Bier A, Engel C, Mangold E, Pagenstecher C, von Knebel Doeberitz M, Holinski-Feder E, Moeslein G, Schulmann K, Plaschke J, Rüschoff J, Schackert HK and The German HNPCC-Consortium. Medizinische Genetik. 2005;17(1):86
  39. Low-level microsatellite instability phenotype in sporadic glioblastoma multiforme. Martinez R, Schackert HK, Appelt H, Plaschke J, Baretton G, Schackert G. J Cancer Res Clin Oncol. 2005 Feb;131(2):87-93
  40. Perspectives of Molecular-/Gene Diagnostics in Hereditary Colorectal Cancer. Schackert HK, Kruger S, Görgens H, Höhl R, Plaschke J, Pistorius S, Saeger HD. Viszeralchirurgie. 2004;39: 420-6
  41. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared to families with MLH1 or MSH2 mutations. Plaschke J, Engel C, Kruger S, Schulmann K, Pagenstecher C, Mangold E, Moeslein G, Gebert J, von Knebel Doeberitz M, Rüschoff J, Loeffler M, Holinski-Feder E, Schackert HK, and The German HNPCC-Consortium. J Clin Oncol. 2004 Nov;22(22): 4486-94
  42. Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry. Muller A, Giuffre G, Edmonston TB, Mathiak M, Roggendorf B, Heinmoller E, Brodegger T, Tuccari G, Mangold E, Buettner R, Ruschoff J; German HNPCC Consortium* German Cancer Aid (Deutsche Krebshilfe). J Mol Diagn. 2004 Nov;6(4):308-15, *Kreuz FR, Kruger S, Plaschke J as member of the German HNPCC Consortium
  43. Ten Novel MSH2 and MLH1 Germline Mutations in Families with HNPCC. Kruger S, Bier A, Plaschke J, Höhl R, Aust DE, Kreuz FR, Pistorius SR, Saeger HD, Rothhammer V, Al-Taie O, Schackert HK. Hum Mutat. 2004 Oct;24(4): 351-2
  44. Two recurrent mutations in MSH2 and MLH1 account for 14% of germline mutations detected in a large series of German patients with hereditary non-polyposis colorectal cancer (HNPCC). Mangold E, Pagenstecher C, Friedl W, Mathiak M, Engel C, Löffler M, Holinski-Feder E, Vogelsang H, Keller G, Plaschke J, Kruger S, Goecke T, Möslein G, Kloor M, Gebert J, Kunstmann E, Brodegger T, Propping P, on behalf of the German HNPCC Consortium. Eur J Hum Genet. 2004;12(S1):179
  45. Molecular pathology in hereditary colorectal cancer. Recommendations of the Collaborative German Study Group on hereditary colorectal cancer funded by the German Cancer Aid (Deutsche Krebshilfe). Rüschoff J, Roggendorf B, Brasch F, Mathiak M, Aust DE, Plaschke J, Mueller W, Poremba C, Kloor M, Keller G, Muders M, Blasenbreu-Vogt S, Rümmele P, Müller A, Büttner R; Collaborative German Study Group on hereditary colorectal cancer funded by the German Cancer Aid (Deutsche Krebshilfe). Pathologe. 2004 May;25(3):178-92
  46. Molecular mechanisms associated with chromosomal and microsatellite instability in sporadic glioblastoma multiforme. Martinez R, Schackert HK, Plaschke J, Baretton G, Appelt H, Schackert G. Oncology. 2004;66(5):395-403
  47. Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue. Plaschke J, Kruger S, Dietmaier W, Gebert J, Sutter C, Mangold E, Pagenstecher C, Holinski-Feder E, Schulmann K, Moslein G, Ruschoff J, Engel C, Evans G, Schackert HK; German HNPCC Consortium. Hum Mutat. 2004 Mar;23(3):285.
  48. Loss of MSH3 protein expression is frequent in MLH1-deficient colorectal cancer and is associated with disease progression. Plaschke J, Kruger S, Jeske B, Theissig F, Kreuz FR, Pistorius S, Saeger HD, Iaccarino I, Marra G, Schackert HK. Cancer Res. 2004 Feb 1;64(3):864-70
  49. Genomic rearrangements of hMSH6 contribute to the genetic predisposition in suspected hereditary non-polyposis colorectal cancer syndrome. Plaschke J, Rüschoff J, Schackert HK. J Med Genet. 2003 Aug;40(8):597-600
  50. Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines. Seitz S, Wassmuth P, Plaschke J, Schackert HK, Karsten U, Santibanez-Koref MF, Schlag PM, Scherneck S. Genes Chromosomes Cancer. 2003 May;37(1):29-35
  51. Identification of six novel MSH2 and MLH1 germline mutations in HNPCC. Kruger S, Plaschke J, Jeske B, Gorgens H, Pistorius SR, Bier A, Kreuz FR, Theissig F, Aust DE, Saeger HD, Schackert HK. Hum Mutat. 2003 Apr;21(4):445-6
  52. Methylenetetrahydrofolate reductase polymorphisms and risk of sporadic and hereditary colorectal cancer with or without microsatellite instability. Plaschke J, Schwanebeck U, Pistorius S, Saeger HD, Schackert HK. Cancer Lett. 2003 Mar 10;191(2):179-85
  53. Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation. Plaschke J, Kruger S, Pistorius S, Theissig F, Saeger HD, Schackert HK. Int J Cancer. 2002 Feb 10;97(5):643-8
  54. Seven novel MLH1 and MSH2 germline mutations in hereditary nonpolyposis colorectal cancer. Kruger S, Plaschke J, Pistorius S, Jeske B, Haas S, Kramer H, Hinterseher I, Bier A, Kreuz FR, Theissig F, Saeger HD, Schackert HK. Hum Mutat. 2002 Jan;19(1):82
  55. Combined molecular and clinical approach for decision making for surgery in HNPCC patients: a report on three cases in two families. Pistorius SR, Nagel M, Kruger S, Plaschke J, Kruppa C, Wehrmann U, Schackert HK, Saeger HD. Int J Colorectal Dis. 2001 Nov;16(6):402-7
  56. DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. Holinski-Feder E, Müller-Koch Y, Friedl W, Moeslein G, Keller G, Plaschke J, Ballhausen W, Gross M, Baldwin-Jedele K, Jungck M, Mangold E, Vogelsang H, Schackert HK, Lohsea P, Murken J, Meitinger T. J Biochem Biophys Methods. 2001 Jan 30;47(1-2):21-32
  57. Nanoscale palladium metallization of DNA. Richter J, Seidel R, Kirsch R, Mertig M, Pompe W, Plaschke J, Schackert HK. Adv Mater. 2000;12:507-10
  58. Clinical consequences of molecular diagnosis in families with mismatch repair gene germline mutations. Pistorius SR, Kruppa C, Haas S, Plaschke J, Kruger S, Bulitta CJ, Nagel M, Saeger HD, Schackert HK. Int J Colorectal Dis. 2000 Nov;15(5-6):255-63
  59. BRCA2 germline mutations among early onset breast cancer patients unselected for family history of the disease. Plaschke J, Commer T, Jacobi C, Schackert HK, Chang-Claude J. J Med Genet. 2000 Sep;37(9):E17
  60. Sequence analysis of the mismatch repair gene hMSH6 in the germline of patients with familial and sporadic colorectal cancer. Plaschke J, Kruppa C, Tischler R, Bocker T, Pistorius S, Dralle H, Rüschoff J, Saeger HD, Fishel R, Schackert HK. Int J Cancer. 2000 Mar 1;85(5):606-13
  61. Quantitative differences between aberrant transcripts which occur as common isoforms and due to mutation-based exon skipping of the mismatch repair gene hMLH1. Plaschke J, Bulitta C, Saeger HD, Schackert HK. Clin Chem Lab Med. 1999 Sep;37(9):883-7
  62. A microsatellite map of wheat. Röder MS, Korzun V, Wendehake K, Plaschke J, Tixier MH, Leroy P, Ganal MW. Genetics. 1998 Aug;149(4):2007-23
  63. Evidence that TSG101 aberrant transcripts are PCR artefacts. Hampl M, Hampl J, Plaschke J, Fitze G, Schackert G, Saeger HD, Schackert HK. Biochem Biophys Res Commun. 1998 Jul 30;248(3):753-60
  64. Doublex sequencing in molecular diagnosis of hereditary diseases. Plaschke J, Voss H, Hahn M, Ansorge W, Schackert HK. Biotechniques. 1998 May;24(5):838-41
  65. Molecular diagnosis and clinical consequences in families with HNPCC syndrome. Pistorius S, Plaschke J, Kruppa C, Rüschoff J, Nagel M, Saeger HD, Schackert HK. Langenbecks Arch Chir Suppl Kongressbd. 1998;115(Suppl I):293-7
  66. Sequence analysis of BRCA1 gene in young breast cancer patients and/or positive family history. Hampl M, Plaschke J, Burgemeister R, Schwarz P, Saeger HD, Schackert HK. Langenbecks Arch Chir Suppl Kongressbd. 1998;115(Suppl I):267-72
  67. An intronic germline transition in the HNPCC gene hMSH2 is associated with sporadic colorectal cancer. Goessl C, Plaschke J, Pistorius S, Hahn M, Frank S, Hampl M, Görgens H, Koch R, Saeger HD, Schackert HK. Eur J Cancer. 1997 Oct;33(11):1869-74
  68. The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors. Frank S, Müller J, Plaschke J, Hahn M, Hampl J, Hampl M, Pistorius S, Schackert G, Schackert HK. Cancer Res. 1997 Jul 1;57(13):2638-41
  69. The use of wheat aneuploids fort he chromosomal assignment of microsatellite loci. Plaschke J, Börner A, Wendehake K, Ganal MW, Röder MS. Euphytica. 1996;89:33-40
  70. Differences in recombination frequency during male and female gametogenesis in rye, Secale cereale L. Korzun V, Plaschke J, Börner A, Koebner RMD. Plant Breeding. 1996; 115:422-4
  71. The relationship between the dwarfing genes of wheat and rye. Börner A, Plaschke J, Korzun V, Worland AJ. Euphytica. 1996;89:69-75
  72. Mapping the GA3-intensivity dwarfing gene ct1 on chromosome 7 in rye. Plaschke J, Korzun V, Koebner RMD, Börner A. Plant Breeding. 1995;113-6
  73. Abundance, variability and chromosomal location of microsatellites in wheat. Röder MS, Plaschke J, König SU, Börner A, Sorrells ME, Tanksley SD, Ganal MW. Mol Gen Genet. 1995 Feb 6;246(3):327-33
  74. Detection of genetic diversity in closely related bread wheat using microsatellite markers. Plaschke J, Ganal MW, Röder MS. Theor Appl Genet. 1996:91:1001-7
  75. Contruction and screening of a rye DNA library for RFLP mapping. Korzun V, Kartel N, Plaschke J, Börner A. Cerel Res Comm. 1994;22:151-7
  76. RFLP mapping of genes affecting plant height and growth habit in rye. Plaschke J, Börner A, Xie DX, Koebner RMD, Schlegel R, Gale MD. Theor Appl Genet. 1993;85:1049-54
  77. Pleiotropic effects of genes for reduced height (Rht) and day-lenght insensitivity (Ppd) on yield and ist components for wheat grown in middle Europe. Börner A, Worland AJ, Plaschke J, Schumann E, Law CN. Plant Breeding. 1993;111:204-16